Vaxart Total Revenue from 2010 to 2024

VXRT Stock  USD 0.61  0.01  1.67%   
Vaxart Total Revenue yearly trend continues to be comparatively stable with very little volatility. Total Revenue will likely drop to about 7 M in 2024. Total Revenue is the total amount of income generated by the sale of goods or services related to Vaxart's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
1985-09-30
Previous Quarter
6.4 M
Current Value
4.9 M
Quarterly Volatility
22.6 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 M, Interest Expense of 1.4 M or Total Revenue of 7 M, as well as many indicators such as Price To Sales Ratio of 10.68, Dividend Yield of 0.0 or PTB Ratio of 2.34. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.
  
Check out the analysis of Vaxart Correlation against competitors.

Latest Vaxart's Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Vaxart Inc over the last few years. Total revenue comprises all receipts Vaxart Inc generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Vaxart's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

Vaxart Total Revenue Regression Statistics

Arithmetic Mean17,412,870
Geometric Mean8,339,745
Coefficient Of Variation106.62
Mean Deviation14,351,420
Median9,300,000
Standard Deviation18,565,482
Sample Variance344.7T
Range68.6M
R-Value(0.66)
Mean Square Error211.7T
R-Squared0.43
Significance0.01
Slope(2,721,284)
Total Sum of Squares4825.5T

Vaxart Total Revenue History

2024M
20237.4 M
2022107 K
2021892 K
2020M
20199.9 M
20184.2 M

About Vaxart Financial Statements

Vaxart shareholders use historical fundamental indicators, such as Total Revenue, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue7.4 MM

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.